COMPASS Pathways Ownership | Who Owns COMPASS Pathways?
COMPASS Pathways Ownership Summary
COMPASS Pathways is owned by 59.39% institutional investors, 12.12% insiders, and 28.49% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 9.33% of CMPS shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.25% of its assets in COMPASS Pathways shares.
CMPS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | COMPASS Pathways | 59.39% | 12.12% | 28.49% |
| Sector | Healthcare Stocks | 42.50% | 10.81% | 46.69% |
| Industry | Medical Care Facilities Stocks | 45.06% | 12.64% | 42.30% |
| Idea | Psychedelic Stocks List | 31.75% | 11.99% | 56.26% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Rtw investments, lp | 8.71M | 9.33% | $49.89M |
| Deep track capital, lp | 7.86M | 8.42% | $45.04M |
| Millennium management | 3.41M | 4.99% | $12.90M |
| Gmt capital | 2.84M | 3.05% | $16.30M |
| Tang capital management | 2.20M | 2.36% | $12.61M |
| Ubs group | 2.14M | 2.30% | $12.29M |
| Ark investment management | 2.12M | 2.27% | $12.15B |
| Nantahala capital management | 1.73M | 1.85% | $9.91M |
| Pfm health sciences, lp | 1.66M | 1.78% | $9.53M |
| Jefferies financial group | 1.38M | 1.48% | $7.89M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Founders fund vii management | 278.88K | 93.02% | $1.60M |
| Ally bridge group (ny) | 1.03M | 3.58% | $5.88M |
| Propel bio management | 510.00K | 2.93% | $2.92M |
| Lion point capital, lp | 58.00K | 1.89% | $332.34K |
| Aisling capital management lp | 1.20M | 1.50% | $6.87M |
| Eagle health investments lp | 935.45K | 1.41% | $5.36M |
| Deep track capital, lp | 7.86M | 1.26% | $45.04M |
| Dafna capital management | 811.05K | 1.15% | $4.65M |
| Blue owl capital lp | 604.91K | 1.08% | $3.47M |
| Gmt capital | 2.84M | 0.74% | $16.30M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Jefferies financial group | 1.38M | 0.04% | 1.38M |
| Ameriprise financial | 1.21M | 0.00% | 1.21M |
| Gmt capital | 2.84M | 0.74% | 1.06M |
| Two sigma investments, lp | 1.08M | 0.01% | 960.68K |
| Eagle health investments lp | 935.45K | 1.41% | 935.45K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Tcg crossover management | - | - | -3.86M |
| Vivo capital | - | - | -3.36M |
| Nantahala capital management | 1.73M | 0.34% | -2.45M |
| Laurion capital management lp | - | - | -1.76M |
| Woodline partners lp | - | - | -1.76M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Jefferies financial group | 1.38M | 0.04% | 1.38M | $7.89M |
| Ameriprise financial | 1.21M | 0.00% | 1.21M | $6.93B |
| Eagle health investments lp | 935.45K | 1.41% | 935.45K | $5.36M |
| Centerbook partners lp | 636.15K | 0.18% | 636.15K | $3.65M |
| Propel bio management | 510.00K | 2.93% | 510.00K | $2.92M |
Sold Out
| Holder | Change |
|---|---|
| American capital advisory | -5.00 |
| Ifp advisors | -10.00 |
| Corecap advisors | -10.00 |
| Nelson, van denburg & campbell wealth management group | -15.00 |
| Jamison private wealth management | -20.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 166 | 12.93% | 55,434,535 | 8.93% | 59 | 2.00% | 87 | 42.62% | 25 | -30.56% |
| Jun 30, 2025 | 150 | 7.14% | 51,720,681 | 3.71% | 55 | 1.77% | 61 | -1.61% | 38 | 40.74% |
| Mar 31, 2025 | 142 | 5.19% | 51,907,706 | 67.77% | 58 | 2.84% | 64 | 8.47% | 26 | - |
| Dec 31, 2024 | 114 | -17.99% | 18,014,918 | -45.03% | 26 | 1.15% | 52 | - | 21 | -19.23% |
| Sep 30, 2024 | 137 | 4.58% | 32,772,645 | 15.26% | 47 | 2.77% | 52 | - | 26 | 36.84% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 2.16M | 2.25% | -7.69K |
| ARK Genomic Revolution | 1.61M | 1.68% | -164.64K |
| HSBC GIF Glb Eq Sust Hlthcare AC USD | 1.08M | 1.12% | 1.08M |
| International Biotechnology Ord | 643.07K | 0.67% | 98.35K |
| Nikko Gbl All Biological Genome Eq MF | 316.75K | 0.46% | -67.45K |
| Columbia Small Cap Value Discv A | 392.51K | 0.41% | 392.51K |
| Columbia Small Cap Value I A | 392.51K | 0.41% | 392.51K |
| iShares Biotechnology ETF | 316.85K | 0.33% | - |
| TEQ- Disruptive Tech In I-III | 249.99K | 0.26% | 115.35K |
| Putnam Sustainable Future A | 162.90K | 0.24% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
| Oct 24, 2024 | Malievskaia Ekaterina | - | Sell | - |
| Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
| Oct 24, 2024 | Goldsmith George Jay | - | Sell | - |
| Sep 26, 2024 | ATAI Life Sciences N.V. | - | Sell | $16.09M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | 4 |
CMPS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools